Publikationen

Publikationen

Ohne Jahr

  1. .

2025

  1. Tasdogan A, Sullivan RJ, Katalinic A, Lebbe C, Whitaker D, Puig S, van de Poll-Franse LV, Massi D, Schadendorf D. Cutaneous melanoma. Nature reviews. Disease primers 2025;11(1):23. doi:10.1038/s41572-025-00603-8
  2. Eisemann N, Bunk S, Mukama T, Baltus H, Elsner SA, Gomille T, Hecht G, Heywang-Köbrunner S, Rathmann R, Siegmann-Luz K, Töllner T, Vomweg TW, Leibig C, Katalinic A. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening.. Nature medicine 2025;31(3):917-924. doi:10.1038/s41591-024-03408-6
  3. Bertram S, Schliemann A, Katalinic A, Kim-Wanner SZ, Pritzkuleit R, Twardella D, Waldmann A. Characteristics of patients with non-small cell lung cancer and either limited or extensive synchronous metastatic spread in Germany-a population-based cancer registry cohort study.. Translational lung cancer research 2025;14(10):4422-4435. doi:10.21037/tlcr-2025-342
  4. Greystoke A, Daumont MJ, Rault C, Baltus H, Ding PQ, Emanuel G, Lucherini S, Vo L, Saglimbene VM, Ralphs E, Leal C, Schoemaker MJ, Katalinic A, Waldmann A, Cheung WY. Real-world treatment patterns and outcomes for patients with non-metastatic non-small cell lung cancer: retrospective analyses in Canada, England, and Germany.. BMC pulmonary medicine 2025;25(1):265. doi:10.1186/s12890-025-03715-9
  5. Bertram S, Schliemann A, Katalinic A, Kim-Wanner SZ, Pritzkuleit R, Twardella D, Waldmann A. Overall survival and progression-free survival of patients with non-small cell lung cancer and either limited or extensive synchronous metastatic spread in Germany-a population-based cancer registry cohort study.. Translational lung cancer research 2025;14(10):4436-4448. doi:10.21037/tlcr-2025-344
  6. Müller JA, Bedir A, Katalinic A, Oesterling F, Graw A, Kluttig A, Corradini S, Vordermark D, Medenwald D. Research with cancer registry data in radiation oncology-current possibilities and perspectives : A narrative review.. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 2025. doi:10.1007/s00066-025-02486-w
  7. Wolgast N, Amelunxen E, Fransecky L, Altrock P, Beder T, Ronnacker J, Peters F, Kim-Wanner SZ, Brüggemann M, Pott C, Katalinic A, Baldus CD, Baden D. Epidemiology and survival of patients with T-cell prolymphocytic leukemia.. Blood cancer journal 2025;15(1):206. doi:10.1038/s41408-025-01428-0
  8. Baltus H, Hübner J, Garbe C, Hagenström K, Rohr M, Hischke S, Augustin J, Augustin M, Katalinic A, Eisemann N. Evaluation of skin cancer screening in Germany - a Microsimulation.. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2025;23(1):19-27. doi:10.1111/ddg.15539
  9. Trama A, Bernasconi A, Cañete A, Carulla M, Daubisse-Marliac L, Rossi S, De Angelis R, Sanvisens A, Katalinic A, Paapsi K, Went P, Mousavi M, Blum M, Eberle A, Lamy S, Capocaccia R, Didonè F, Botta L. Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study.. European journal of cancer (Oxford, England : 1990) 2025;214:115147. doi:10.1016/j.ejca.2024.115147
  10. Di Carlo V, Eberle A, Stiller C, Bennett D, Katalinic A, Marcos-Gragera R, Girardi F, Larønningen S, Schultz A, Lima CA, Coleman MP, Allemani C. Sex differences in survival from melanoma of the skin: The role of age, anatomic location and stage at diagnosis: A CONCORD-3 study in 59 countries.. European journal of cancer (Oxford, England : 1990) 2025;217:115213. doi:10.1016/j.ejca.2024.115213
  11. Germer S, Rudolph C, Katalinic A, Rath N, Rausch K, Handels H. Lung Cancer Survival Estimation Using Data from Seven German Cancer Registries.. Studies in health technology and informatics 2025;327:457-461. doi:10.3233/SHTI250379
  12. Bernasconi A, Toss A, Zattarin E, Mousavi SM, Blum M, Kuehni CE, Katalinic A, Trallero J, Rapiti E, Maso LD, Botta L, Rossi S, Peccatori F, Trama A. Prognosis of Breast Cancer in European female adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results.. Breast (Edinburgh, Scotland) 2025;82:104472. doi:10.1016/j.breast.2025.104472
  13. Kusche H, Gundler C, Johanns O, Sauerberg M, Wicker T, Heinrichs V, Dettmer D, Goeken N, Langholz M, Luttmann S, Mazuch P, Pritzkuleit R, Rath N, Rausch K, Sha LK, Sieber A, Katalinic A, Nennecke A. Leveraging machine-learning techniques to detect recurrences in cancer registry data: A multi-registry validation study using German lung cancer data.. European journal of cancer (Oxford, England : 1990) 2025;227:115604. doi:10.1016/j.ejca.2025.115604
  14. Hoogendijk R, Capocaccia R, van der Lugt J, Kranendonk MEG, Hoving EW, Wesseling P, Visser O, van Vuurden DG, Gatta G, Karim-Kos HE. Long-term survival and cure fraction estimates for paediatric central nervous system tumours in 31 European countries (EUROCARE-6): a population-based study.. The Lancet. Oncology 2025;26(8):1091-1099. doi:10.1016/S1470-2045(25)00297-9
  15. Botta L, Capocaccia R, Bernasconi A, Rossi S, Galceran J, Dal Maso L, Lepage C, Molinié F, Bouvier AM, Marcos-Gragera R, Vener C, Guevara M, Murray D, Ragusa R, Gatta G, Jooste V. The impact of cancer survivors' extra risk of noncancer mortality on net survival estimation.. American journal of epidemiology 2025;194(11):3316-3324. doi:10.1093/aje/kwaf148
  16. Tetzlaff F, Barnes B, Jansen L, Peters F, Schultz A, Katalinic A, Kraywinkel K, Michalski N, Nowossadeck E, Hoebel J. Widening socioeconomic inequalities in cancer incidence and related potential to reduce cancer between 2008 and 2019 in Germany.. Scientific reports 2025;15(1):32232. doi:10.1038/s41598-025-17859-5
  17. Baden D, Wolgast N, Altrock PM, Steinhäuser S, Voran J, Beder T, Hecht M, Baden C, Bastian L, Ronckers C, Müller-Nordhorn J, Kim-Wanner SZ, Neumann M, Fransecky L, Cario G, Röllig C, Katalinic A, Baldus CD. Epidemiology, survival, and treatment of acute myeloid and lymphoblastic leukaemia in Germany: a nationwide population-based registry analysis.. The Lancet regional health. Europe 2025;59:101503. doi:10.1016/j.lanepe.2025.101503
  18. Wiegers NC, Germer S, Rudolph C, Rath N, Rausch K, Katalinic A, Handels H. Evaluating Imputation Techniques for Survival Data Utilizing Kaplan-Meier Curves.. Studies in health technology and informatics 2025;332:17-21. doi:10.3233/SHTI251487
  19. Crocetti E, Bennett D, Jooste V, Rossi S, Maso LD, Marcos-Gragera R, Smits S, Zagar T, Troussard X, Mayer-da-Silva A, Daubisse-Marliac L, Lourenço A, Katalinic A, Sanchez MJ, Vener C, Mousavi M, Ziliani V, Gatta G. Skin melanoma survival is improving in Europe but regional differences persist: Results of the EUROCARE-6 study.. European journal of cancer (Oxford, England : 1990) 2025;231:116061. doi:10.1016/j.ejca.2025.116061
  20. Elsner SA, Haußmann E, Grieger P, Hadwiger M, Rieck A, Hacker A, Heywang-Köbrunner S, Katalinic A. Optimising breast cancer screening in national mammography screening centres: challenges and insights on implementing additional ultrasound for women with dense breast tissue - a qualitative study.. BMC cancer 2025;25(1):1684. doi:10.1186/s12885-025-15145-1

2024

  1. Weigel S, Katalinic A. Structured screening for sporadic breast cancer.. Radiologie (Heidelberg, Germany) 2024;64(6):463-470. doi:10.1007/s00117-024-01283-3
  2. Grieger P, Eisemann N, Hammersen F, Rudolph C, Katalinic A, Waldmann A. Initial Evidence of a Possible Effect of HPV Vaccination on Cancer Incidence in Germany—Focus on Cervical Cancer.. Deutsches Arzteblatt international 2024;121(13):415-421. doi:10.3238/arztebl.m2024.0062
  3. Lange B, Jaeger VK, Harries M, Rücker V, Streeck H, Blaschke S, Petersmann A, Toepfner N, Nauck M, Hassenstein MJ, Dreier M, von Holt I, Budde A, Bartz A, Ortmann J, Kurosinski MA, Berner R, Borsche M, Brandhorst G, Brinkmann M, Budde K, Deckena M, Engels G, Fenzlaff M, Härtel C, Hovardovska O, Katalinic A, Kehl K, Kohls M, Krüger S, Lieb W, Meyer-Schlinkmann KM, Pischon T, Rosenkranz D, Rübsamen N, Rupp J, Schäfer C, Schattschneider M, Schlegtendal A, Schlinkert S, Schmidbauer L, Schulze-Wundling K, Störk S, Tiemann C, Völzke H, Winter T, Klein C, Liese J, Brinkmann F, Ottensmeyer PF, Reese JP, Heuschmann P, Karch A. Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project.. Infection 2024;52(1):139-153. doi:10.1007/s15010-023-02071-2
  4. Eisemann N, Schumann L, Baltus H, Labohm L, Kraywinkel K, Katalinic A. Longer Survival From Melanoma in Germany.. Deutsches Arzteblatt international 2024;121(2):45-51. doi:10.3238/arztebl.m2023.0242
  5. De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R, Guevara M, Randi G, Bettio M, Botta L, Guzzinati S, Dal Maso L, Rossi S. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study.. The Lancet. Oncology 2024;25(3):293-307. doi:10.1016/S1470-2045(23)00646-0
  6. Katalinic M, Schenk M, Franke S, Katalinic A, Neumuth T, Dietz A, Stoehr M, Gaebel J. Generation of a Realistic Synthetic Laryngeal Cancer Cohort for AI Applications.. Cancers 2024;16(3). doi:10.3390/cancers16030639
  7. Trama A, Botta L, Stiller C, Visser O, Cañete-Nieto A, Spycher B, Bielska-Lasota M, Katalinic A, Vener C, Innos K, Marcos-Gragera R, Paapsi K, Guevara M, Demuru E, Mousavi SM, Blum M, Eberle A, Ferrari A, Bernasconi A, Lasalvia P. Survival of European adolescents and young adults diagnosed with cancer in 2010-2014.. European journal of cancer (Oxford, England : 1990) 2024;202:113558. doi:10.1016/j.ejca.2024.113558
  8. Schumann L, Hadwiger M, Eisemann N, Katalinic A. Lead-Time Corrected Effect on Breast Cancer Survival in Germany by Mode of Detection.. Cancers 2024;16(7). doi:10.3390/cancers16071326
  9. Nanz L, Keim U, Katalinic A, Meyer T, Garbe C, Leiter U. Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma.. Cancers 2024;16(3). doi:10.3390/cancers16030606
  10. Bouvier AM, Jooste V, Lillini R, Marcos-Gragera R, Katalinic A, Giorgi Rossi P, Launoy G, Bouvier V, Guevara M, Ardanaz E, Rapiti Aylward E, Innos K, Barranco MR, Sant M. Differences in survival and recurrence of colorectal cancer by stage across population-based European registries.. International journal of cancer 2024;155(5):807-815. doi:10.1002/ijc.34944
  11. Schulz NA, Carus J, Wiederhold AJ, Johanns O, Peters F, Rath N, Rausch K, Holleczek B, Katalinic A, Gundler C. Learning debiased graph representations from the OMOP common data model for synthetic data generation.. BMC medical research methodology 2024;24(1):136. doi:10.1186/s12874-024-02257-8
  12. Sant M, Vener C, Lillini R, Rossi S, Bonfarnuzzo S, Marcos-Gragera R, Maynadié M, Innos K, Paapsi K, Visser O, Bernasconi A, Demuru E, Di Benedetto C, Mousavi SM, Blum M, Went P, Serraino D, Bennett D, Sánchez MJ, De Angelis R. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study.. The Lancet. Oncology 2024;25(6):731-743. doi:10.1016/S1470-2045(24)00141-4
  13. Käding N, Waldeck F, Meier B, Boutin S, Borsche M, Balck A, Föh B, Kramer J, Klein C, Katalinic A, Rupp J. Influence of non-pharmaceutical interventions during the COVID-19 pandemic on respiratory viral infections - a prospective population-based cohort study.. Frontiers in public health 2024;12:1415778. doi:10.3389/fpubh.2024.1415778
  14. Virgili G, Capocaccia R, Botta L, Bennett D, Hadjistilianou T, Innos K, Karim-Kos H, Kuehni CE, Kuhnel U, Mazzini C, Canete Nieto A, Paapsi K, Parravano M, Ronckers CM, Rossi S, Stiller C, Vicini G, Visser O, Gatta G. Survival and Health Care Burden of Children With Retinoblastoma in Europe.. JAMA ophthalmology 2024;142(11):1062-1070. doi:10.1001/jamaophthalmol.2024.4140
  15. Germer S, Rudolph C, Labohm L, Katalinic A, Rath N, Rausch K, Holleczek B, Handels H. Survival analysis for lung cancer patients: A comparison of Cox regression and machine learning models.. International journal of medical informatics 2024;191:105607. doi:10.1016/j.ijmedinf.2024.105607
  16. Schmidt H, Baust K, Calaminus G, Hohls L, Tetzner K, Griech N, Haugke H, Baltus H, Elsner S, Katalinic A, Becker H, Cytera C, Gebauer J, Kock-Schoppenhauer AK, Neumann A, Denzer C, Schündeln MM, Faber J, Sattler C, Frühwald MC, Borgmann-Staudt A, Barnbrock A, Metzler M, Escherich G, König IR, Menrath I, Langer T. Effectiveness of structured, multidisciplinary long-term care for pediatric cancer survivors: protocol of the multicenter, randomized-controlled AELKI study.. Trials 2024;25(1):597. doi:10.1186/s13063-024-08377-2
  17. Erikson K, Heidenreich A, Labunska V, Beach R, Cremers F, Rades D, Grisanti S, Katalinic A, Kakkassery V. Evaluation of ocular and systemic endpoints after radiation of posterior uveal melanoma - A systematic review and meta-analysis.. Heliyon 2024;10(18):e36468. doi:10.1016/j.heliyon.2024.e36468
  18. Indini A, Didoné F, Massi D, Puig S, Casadevall JR, Bennett D, Katalinic A, Sanvisens A, Ferrari A, Lasalvia P, Demuru E, Ragusa R, Mayer-da-Silva A, Blum M, Mousavi M, Kuehni C, Mihor A, Mandalà M, Trama A. Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results.. European journal of cancer (Oxford, England : 1990) 2024;213:115079. doi:10.1016/j.ejca.2024.115079
  19. Manz K, Weitmann K, Theen S, Robers G, Pritzkuleit R, Katalinic A, Hoffmann W. Cancer incidence and mortality in the occupational cohort of a German toxic waste landfill: a retrospective cohort study.. BMC public health 2024;24(1):3560. doi:10.1186/s12889-024-21134-z

2023

  1. Katalinic A, Halber M, Meyer M, Pflüger M, Eberle A, Nennecke A, Kim-Wanner SZ, Hartz T, Weitmann K, Stang A, Justenhoven C, Holleczek B, Piontek D, Wittenberg I, Heßmer A, Kraywinkel K, Spix C, Pritzkuleit R. Population-Based Clinical Cancer Registration in Germany.. Cancers 2023;15(15). doi:10.3390/cancers15153934
  2. Waldmann A, Borchers P, Katalinic A. Temporal trends in age- and stage-specific incidence of colorectal adenocarcinomas in Germany.. BMC cancer 2023;23(1):1180. doi:10.1186/s12885-023-11660-1
  3. Girardi F, Di Carlo V, Stiller C, Gatta G, Woods RR, Visser O, Lacour B, Tucker TC, Coleman MP, Allemani C. Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3).. Neuro-oncology 2023;25(3):593-606. doi:10.1093/neuonc/noac232
  4. Girardi F, Matz M, Stiller C, You H, Marcos Gragera R, Valkov MY, Bulliard JL, De P, Morrison D, Wanner M, O'Brian DK, Saint-Jacques N, Coleman MP, Allemani C. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3).. Neuro-oncology 2023;25(3):580-592. doi:10.1093/neuonc/noac217
  5. Heywang-Köbrunner SH, Hacker A, Jänsch A, Hertlein M, Mieskes C, Elsner S, Sinnatamby R, Katalinic A. Use of novel artificial intelligence computer-assisted detection (AI-CAD) for screening mammography: an analysis of 17,884 consecutive two-view full-field digital mammography screening exams.. Acta radiologica (Stockholm, Sweden : 1987) 2023;64(10):2697-2703. doi:10.1177/02841851231187382
  6. Keim U, Katalinic A, Holleczek B, Wakkee M, Garbe C, Leiter U. Incidence, mortality and trends of cutaneous squamous cell carcinoma in Germany, the Netherlands, and Scotland.. European journal of cancer (Oxford, England : 1990) 2023;183:60-68. doi:10.1016/j.ejca.2023.01.017
  7. Eisemann N, Schnoor M, Rakusa E, Braren-von Stülpnagel CC, Katalinic A, Ludwig M, Sonntag B, Ludwig AK, Elsner SA. Psychosocial health and quality of life in ICSI and naturally conceived adolescents: a cross-sectional comparison.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2023;32(8):2223-2234. doi:10.1007/s11136-023-03382-5
  8. Hammersen F, Fischer D, Pursche T, Strobel AM, Katalinic A, Labohm L, Waldmann A. Young Adult German Breast Cancer Patients Participating in a Three-Week Inpatient Mother-Child Rehab Program Have High Needs for Supportive Care.. Cancers 2023;15(6). doi:10.3390/cancers15061770
  9. Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, Lamy S, Jooste V, Di Benedetto C, De Angelis R. Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes.. Frontiers in oncology 2023;13:1114701. doi:10.3389/fonc.2023.1114701
  10. Rudolph C, Engholm G, Pritzkuleit R, Storm HH, Katalinic A. Colorectal Cancer Survival in German-Danish Border Regions-A Registry-Based Cohort Study.. Cancers 2023;15(18). doi:10.3390/cancers15184474
  11. Struck JP, Ozimek T, Schnoor M, Offermann A, Guenther M, Roesch MC, Wießmeye JR, Katalinic A, Perner S, Borgmann H, Merseburger AS, Kramer MW. The Role of Urine and Washing Cytology in Primary Transurethral Resection of Bladder Tumours.. Urologia internationalis 2023;107(8):792-800. doi:10.1159/000531443
  12. Hübner J, Baltus H, Eisemann N, Rohr M, Schumann L, Augustin J, Hagenström K, Wolf S, Garbe C, Augustin M, Katalinic A. Evaluation of early skin cancer detection in Germany with cancer registry data - challenges, solutions and current trends.. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2023;21 Suppl 5:13-20. doi:10.1111/ddg.15171
  13. Garbe C, Augustin M, Augustin J, Baltus H, Eisemann N, Hübner J, Katalinic A, Wolf S, Hagenström K. Evaluation of skin cancer screening in Germany - participation, tumor detection and interval tumors based on SHI data.. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2023;21 Suppl 5:3-11. doi:10.1111/ddg.15170
  14. Schumann L, Eisemann N, Augustin J, Kieschke J, Meyer M, Kajüter H, Katalinic A. Association of early-stage incidence and mortality in malignant melanoma - a population-based ecological study.. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2023;21 Suppl 5:33-40. doi:10.1111/ddg.15218
  15. Schliemann A, Teroerde A, Beurer B, Hammersen F, Fischer D, Katalinic A, Labohm L, Strobel AM, Waldmann A. Reduced Psychosocial Well-Being among the Children of Women with Early-Onset Breast Cancer.. Current oncology (Toronto, Ont.) 2023;30(12):10057-10074. doi:10.3390/curroncol30120731
  16. Wolf S, Augustin M, Hagenström K, Garbe C, Baltus H, Eisemann N, Hübner J, Katalinic A, Augustin J. Evaluation of skin cancer screening in Germany - Spatiotemporal associations between skin cancer screening and skin cancer mortality based on ambulatory claims data.. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2023;21 Suppl 5:22-31. doi:10.1111/ddg.15172

2022

  1. Baldermann C. The UV Protection Alliance in Germany-Purpose and goals.. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2022;119(3):223-233. doi:10.1007/s00347-021-01543-w
  2. Peters E, Alabid A, Elsner S, Klein C, Borsche M, Rupp J, Katalinic A. Quality assurance follow-up survey of the ELISA cohort study on the prevalence of COVID-19: The view of study participants - What is well received?.. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 2022;174:59-69. doi:10.1016/j.zefq.2022.06.001
  3. Pigeot I, Bongaerts B, Eberle A, Katalinic A, Kieschke J, Luttmann S, Meyer M, Nennecke A, Rathmann W, Stabenow R, Wilsdorf-Köhler H, Kollhorst B, Reinders T. Linkage of claims data with data from epidemiological cancer registries: possibilities and limitations in the German federal states.. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2022;65(5):615-623. doi:10.1007/s00103-021-03475-x
  4. Schmutzler RK, Schmitz-Luhn B, Borisch B, Devilee P, Eccles D, Hall P, Balmaña J, Boccia S, Dabrock P, Emons G, Gaissmaier W, Gronwald J, Houwaart S, Huster S, Kast K, Katalinic A, Linn SC, Moorthie S, Pharoah P, Rhiem K, Spranger T, Stoppa-Lyonnet D, van Delden JJM, van den Bulcke M, Woopen C. Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors.. Breast care (Basel, Switzerland) 2022;17(2):208-223. doi:10.1159/000517182
  5. Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond S, Bulliard JL, Girardi F, Fowler C, Marcos-Gragera R, Bonaventure A, Saint-Jacques N, Minicozzi P, De P, Rodríguez-Barranco M, Larønningen S, Di Carlo V, Mägi M, Valkov M, Seppä K, Wyn Huws D, Coleman MP, Allemani C. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries.. The Lancet. Child & adolescent health 2022;6(6):409-431. doi:10.1016/S2352-4642(22)00095-5
  6. Vener C, Rossi S, Minicozzi P, Marcos-Gragera R, Poirel HA, Maynadié M, Troussard X, Pravettoni G, De Angelis R, Sant M. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials.. Frontiers in oncology 2022;12:892684. doi:10.3389/fonc.2022.892684
  7. Shan L, Zhang L, Zhu X, Wang Z, Fang S, Lin J, Wang J, Li N, Liu H, Zhang X, Feng Y, Liu J, Pan J, Ye G, Yu X, Tufman A, Katalinic A, Goldmann T, Petersen F, Jiang J, Geng G, Yu X. Chinese never smokers with adenocarcinoma of the lung are younger and have fewer lymph node metastases than smokers.. Respiratory research 2022;23(1):293. doi:10.1186/s12931-022-02199-z
  8. Botta L, Gatta G, Capocaccia R, Stiller C, Cañete A, Dal Maso L, Innos K, Mihor A, Erdmann F, Spix C, Lacour B, Marcos-Gragera R, Murray D, Rossi S. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study.. The Lancet. Oncology 2022;23(12):1525-1536. doi:10.1016/S1470-2045(22)00637-4

2021

  1. Frielitz FS, Dördelmann J, Lemke S, Lange K, Hiort O, Katalinic A, von Sengbusch S. Assessing the benefits and challenges of video consultations for the treatment of children with type 1 diabetes - A qualitative study among diabetes professionals.. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2021;129(11):831-836. doi:10.1055/a-1149-8814
  2. Bouvier AM, Jooste V, Sanchez-Perez MJ, Bento MJ, Rocha Rodrigues J, Marcos-Gragera R, Carmona-Garcia MC, Luque-Fernandez MA, Minicozzi P, Bouvier V, Innos K, Sant M. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study.. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2021;53(5):639-645. doi:10.1016/j.dld.2021.01.021
  3. Sacchetto L, Rosso S, Comber H, Bouchardy C, Broganelli P, Galceran J, Hackl M, Katalinic A, Louwman M, Robsahm TE, Tryggvadottir L, Tumino R, Van Eycken E, Walsh PM, Zadnik V, Zanetti R. Skin melanoma deaths within 1 or 3 years from diagnosis in Europe.. International journal of cancer 2021;148(12):2898-2905. doi:10.1002/ijc.33479
  4. Rudolph CES, Engholm G, Pritzkuleit R, Storm HH, Katalinic A. Survival of breast cancer patients in German-Danish border regions - A registry-based cohort study.. Cancer epidemiology 2021;74:102001. doi:10.1016/j.canep.2021.102001
  5. Lillini R, Tittarelli A, Bertoldi M, Ritchie D, Katalinic A, Pritzkuleit R, Launoy G, Launay L, Guillaume E, Žagar T, Modonesi C, Meneghini E, Amati C, Di Salvo F, Contiero P, Borgini A, Baili P. Water and Soil Pollution: Ecological Environmental Study Methodologies Useful for Public Health Projects. A Literature Review.. Reviews of environmental contamination and toxicology 2021;256:179-214. doi:10.1007/398_2020_58
  6. Waldmann A, Hübner J, Katalinic A. Trends Over Time in Breast-Cancer-Specific Mortality in Germany.. Deutsches Arzteblatt international 2021;118(31-32):538-539. doi:10.3238/arztebl.m2021.0182
  7. Pruessmann J, Pursche T, Hammersen F, Katalinic A, Fischer D, Waldmann A. Conditional Disease-Free and Overall Survival of 1,858 Young Women with Non-Metastatic Breast Cancer and with Participation in a Post-Therapeutic Rehab Programme according to Clinical Subtypes.. Breast care (Basel, Switzerland) 2021;16(2):163-172. doi:10.1159/000507315
  8. Krensel M, Petersen J, Stephan B, Katalinic A, Augustin J. Comparison of patient pathways in the early detection of skin cancer - a claims data analysis.. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2021;19(3):389-398. doi:10.1111/ddg.14318
  9. Keim U, Gandini S, Amaral T, Katalinic A, Holleczek B, Flatz L, Leiter U, Whiteman D, Garbe C. Cutaneous melanoma attributable to UVR exposure in Denmark and Germany.. European journal of cancer (Oxford, England : 1990) 2021;159:98-104. doi:10.1016/j.ejca.2021.09.044
  10. Garbe C, Keim U, Gandini S, Amaral T, Katalinic A, Hollezcek B, Martus P, Flatz L, Leiter U, Whiteman D. Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036.. European journal of cancer (Oxford, England : 1990) 2021;152:18-25. doi:10.1016/j.ejca.2021.04.029
  11. Hammersen F, Pursche T, Fischer D, Katalinic A, Waldmann A. Psychosocial and family-centered support among breast cancer patients with dependent children.. Psycho-oncology 2021;30(3):361-368. doi:10.1002/pon.5585
  12. Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, Van Damme N, Valerianova Z, Atanasov T, Májek O, Mužík J, Nilbert MC, Tybjerg AJ, Innos K, Mägi M, Malila N, Bouvier AM, Bouvier V, Launoy G, Woronoff AS, Cariou M, Robaszkiewicz M, Delafosse P, Poncet F, Katalinic A, Walsh PM, Senore C, Rosso S, Vincerževskienė I, Lemmens VEPP, Elferink MAG, Johannesen TB, Kørner H, Pfeffer F, Bento MJ, Rodrigues J, Alves da Costa F, Miranda A, Zadnik V, Žagar T, Lopez de Munain Marques A, Marcos-Gragera R, Puigdemont M, Galceran J, Carulla M, Chirlaque MD, Ballesta M, Sundquist K, Sundquist J, Weber M, Jordan A, Herrmann C, Mousavi M, Ryzhov A, Hoffmeister M, Brenner H. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study.. The Lancet. Oncology 2021;22(7):1002-1013. doi:10.1016/S1470-2045(21)00199-6

2020

  1. Sirri E, Kieschke J, Vohmann C, Katalinic A, Nennecke A, Ressing M, Eberle A, Holleczek B, Jansen L, Brenner H. Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study.. International journal of cancer 2020;147(6):1548-1558. doi:10.1002/ijc.32931
  2. Sant M, Meneghini E, Bastos J, Rossi PG, Guevara M, Innos K, Katalinic A, Majuelo LG, Marcos-Gragera R, Molinié F, Rapiti E, Vizcaino A, Zadnik V, Minicozzi P. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study.. Breast cancer research and treatment 2020;183(2):439-450. doi:10.1007/s10549-020-05761-9
  3. Minicozzi P, Vicentini M, Innos K, Castro C, Guevara M, Stracci F, Carmona-Garcia M, Rodriguez-Barranco M, Vanschoenbeek K, Rapiti E, Katalinic A, Marcos-Gragera R, Van Eycken L, Sánchez MJ, Bielska-Lasota M, Rossi PG, Sant M. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study.. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2020;46(6):1151-1159. doi:10.1016/j.ejso.2020.02.023
  4. Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, Hübner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program.. International journal of cancer 2020;147(3):709-718. doi:10.1002/ijc.32767
  5. Jansen L, Holleczek B, Kraywinkel K, Weberpals J, Schröder CC, Eberle A, Emrich K, Kajüter H, Katalinic A, Kieschke J, Nennecke A, Sirri E, Heil J, Schneeweiss A, Brenner H. Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States.. Cancers 2020;12(9). doi:10.3390/cancers12092419
  6. Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A. Long-term relative survival from melanoma in Germany 1997-2013.. Melanoma research 2020;30(4):386-395. doi:10.1097/CMR.0000000000000482
  7. Hübner J, Katalinic A, Waldmann A, Kraywinkel K. Long-term Incidence and Mortality Trends for Breast Cancer in Germany.. Geburtshilfe und Frauenheilkunde 2020;80(6):611-618. doi:10.1055/a-1160-5569
  8. Hammersen F, Pursche T, Fischer D, Katalinic A, Waldmann A. Use of Complementary and Alternative Medicine among Young Patients with Breast Cancer.. Breast care (Basel, Switzerland) 2020;15(2):163-170. doi:10.1159/000501193
  9. Arndt V, Holleczek B, Kajüter H, Luttmann S, Nennecke A, Zeissig SR, Kraywinkel K, Katalinic A. Data from Population-based Cancer Registration for Secondary Data Analysis: Methodological Challenges and Perspectives.. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2020;82(S 01):S62-S71. doi:10.1055/a-1009-6466

2019

  1. Hübner J, Lewin P, Pritzkuleit R, Eisemann N, Maier W, Katalinic A. Colorectal cancer screening by colonoscopy and trends in disease-specific mortality: a population-based ecological study of 358 German districts.. International journal of colorectal disease 2019;34(4):599-605. doi:10.1007/s00384-018-03226-6
  2. Sophia Rudolph CE, Katalinic A. [Baseline Incidence of HPV-Associated Invasive and in Situ Cancers in Germany Prior to Potential Vaccination Effects].. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2019;81(12):993-1000. doi:10.1055/a-0631-1988
  3. Rudolph C, Petersen GS, Pritzkuleit R, Storm H, Katalinic A. The acceptance and applicability of a patient-reported experience measurement tool in oncological care: a descriptive feasibility study in northern Germany.. BMC health services research 2019;19(1):786. doi:10.1186/s12913-019-4646-4
  4. Minicozzi P, Van Eycken L, Molinie F, Innos K, Guevara M, Marcos-Gragera R, Castro C, Rapiti E, Katalinic A, Torrella A, Žagar T, Bielska-Lasota M, Giorgi Rossi P, Larrañaga N, Bastos J, Sánchez MJ, Sant M. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer.. International journal of cancer 2019;144(9):2118-2127. doi:10.1002/ijc.31974
  5. Hübner J, Hübner F, Terheyden P, Katalinic A. [Turning point in skin cancer mortality : An analysis of the trend in Germany from 1998 to 2017].. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2019;70(12):989-992. doi:10.1007/s00105-019-04504-2
  6. Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A. A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype.. Journal of the American Academy of Dermatology 2019;80(4):938-946. doi:10.1016/j.jaad.2018.09.018
  7. Garbe C, Keim U, Eigentler TK, Amaral T, Katalinic A, Holleczek B, Martus P, Leiter U. Time trends in incidence and mortality of cutaneous melanoma in Germany.. Journal of the European Academy of Dermatology and Venereology : JEADV 2019;33(7):1272-1280. doi:10.1111/jdv.15322
  8. Deck R, Babaev V, Katalinic A. [Reasons for the Non-Utilisation of an Oncological Rehabilitation. Results of a Written Survey with Patients of Oncological Healthcare Centers].. Die Rehabilitation 2019;58(4):243-252. doi:10.1055/a-0642-1411

2018

  1. Wöckel A, Festl J, Stüber T, Brust K, Krockenberger M, Heuschmann PU, Jírů-Hillmann S, Albert US, Budach W, Follmann M, Janni W, Kopp I, Kreienberg R, Kühn T, Langer T, Nothacker M, Scharl A, Schreer I, Link H, Engel J, Fehm T, Weis J, Welt A, Steckelberg A, Feyer P, König K, Hahne A, Baumgartner T, Kreipe HH, Knoefel WT, Denkinger M, Brucker S, Lüftner D, Kubisch C, Gerlach C, Lebeau A, Siedentopf F, Petersen C, Bartsch HH, Schulz-Wendtland R, Hahn M, Hanf V, Müller-Schimpfle M, Henscher U, Roncarati R, Katalinic A, Heitmann C, Honegger C, Paradies K, Bjelic-Radisic V, Degenhardt F, Wenz F, Rick O, Hölzel D, Zaiss M, Kemper G, Budach V, Denkert C, Gerber B, Tesch H, Hirsmüller S, Sinn HP, Dunst J, Münstedt K, Bick U, Fallenberg E, Tholen R, Hung R, Baumann F, Beckmann MW, Blohmer J, Fasching P, Lux MP, Harbeck N, Hadji P, Hauner H, Heywang-Köbrunner S, Huober J, Hübner J, Jackisch C, Loibl S, Lück HJ, von Minckwitz G, Möbus V, Müller V, Nöthlings U, Schmidt M, Schmutzler R, Schneeweiss A, Schütz F, Stickeler E, Thomssen C, Untch M, Wesselmann S, Bücker A, Buck A, Stangl S. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer.. Geburtshilfe und Frauenheilkunde 2018;78(11):1056-1088. doi:10.1055/a-0646-4630
  2. Wöckel A, Festl J, Stüber T, Brust K, Stangl S, Heuschmann PU, Albert US, Budach W, Follmann M, Janni W, Kopp I, Kreienberg R, Kühn T, Langer T, Nothacker M, Scharl A, Schreer I, Link H, Engel J, Fehm T, Weis J, Welt A, Steckelberg A, Feyer P, König K, Hahne A, Kreipe HH, Knoefel WT, Denkinger M, Brucker S, Lüftner D, Kubisch C, Gerlach C, Lebeau A, Siedentopf F, Petersen C, Bartsch HH, Schulz-Wendtland R, Hahn M, Hanf V, Müller-Schimpfle M, Henscher U, Roncarati R, Katalinic A, Heitmann C, Honegger C, Paradies K, Bjelic-Radisic V, Degenhardt F, Wenz F, Rick O, Hölzel D, Zaiss M, Kemper G, Budach V, Denkert C, Gerber B, Tesch H, Hirsmüller S, Sinn HP, Dunst J, Münstedt K, Bick U, Fallenberg E, Tholen R, Hung R, Baumann F, Beckmann MW, Blohmer J, Fasching PA, Lux MP, Harbeck N, Hadji P, Hauner H, Heywang-Köbrunner S, Huober J, Hübner J, Jackisch C, Loibl S, Lück HJ, von Minckwitz G, Möbus V, Müller V, Nöthlings U, Schmidt M, Schmutzler R, Schneeweiss A, Schütz F, Stickeler E, Thomssen C, Untch M, Wesselmann S, Bücker A, Krockenberger M. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer.. Geburtshilfe und Frauenheilkunde 2018;78(10):927-948. doi:10.1055/a-0646-4522
  3. Pulte D, Weberpals J, Schröder CC, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Jansen L, Brenner H. Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century.. International journal of cancer 2018;143(2):324-332. doi:10.1002/ijc.31322
  4. Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, Chirlaque MD, Coza D, Galceran J, Gavin A, Hackl M, Katalinic A, Larønningen S, Louwman MWJ, Morgan E, Robsahm TE, Sanchez MJ, Tryggvadóttir L, Tumino R, Van Eycken E, Vernon S, Zadnik V, Rosso S. Trends in incidence of thick, thin and in situ melanoma in Europe.. European journal of cancer (Oxford, England : 1990) 2018;92:108-118. doi:10.1016/j.ejca.2017.12.024
  5. Katalinic A. The Burden of Cancer in Germany.. Deutsches Arzteblatt international 2018;115(35-36):569-570. doi:10.3238/arztebl.2018.0569
  6. Jansen L, Buttmann-Schweiger N, Listl S, Ressing M, Holleczek B, Katalinic A, Luttmann S, Kraywinkel K, Brenner H. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site.. Oral oncology 2018;76:8-15. doi:10.1016/j.oraloncology.2017.11.015
  7. Hammersen F, Pursche T, Fischer D, Katalinic A, Waldmann A. [Signs of social inequality in information seeking and evaluation of information among young women with breast cancer - results of a cohort study].. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 2018;139:10-16. doi:10.1016/j.zefq.2018.10.006
  8. Eisemann N, Waldmann A, Holleczek B, Katalinic A. Observed and expected mortality in the German skin cancer screening pilot project SCREEN.. Journal of medical screening 2018;25(3):166-168. doi:10.1177/0969141317734003
  9. Hübner J, Waldmann A, Eisemann N, Noftz M, Geller AC, Weinstock MA, Volkmer B, Greinert R, Breitbart EW, Katalinic A. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening.. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2018;27(6):563-569. doi:10.1097/CEJ.0000000000000392
  10. Hübner J, Eisemann N, Brunßen A, Katalinic A. [Skin cancer screening in Germany: review after ten years].. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2018;61(12):1536-1543. doi:10.1007/s00103-018-2836-6
  11. Hoebel J, Kroll LE, Fiebig J, Lampert T, Katalinic A, Barnes B, Kraywinkel K. Socioeconomic Inequalities in Total and Site-Specific Cancer Incidence in Germany: A Population-Based Registry Study.. Frontiers in oncology 2018;8:402. doi:10.3389/fonc.2018.00402
  12. Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, Holleczek B, Katalinic A, Luttmann S, Sundquist K, Ressing M, Xu L, Hemminki K. Response: Methods for second primary cancers evaluation have to be standardized.. International journal of cancer 2018;142(6):1286-1287. doi:10.1002/ijc.31151

2017

  1. Pulte D, Weberpals J, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H. Survival for patients with rare haematologic malignancies: Changes in the early 21st century.. European journal of cancer (Oxford, England : 1990) 2017;84:81-87. doi:10.1016/j.ejca.2017.07.014
  2. Leiter U, Keim U, Eigentler T, Katalinic A, Holleczek B, Martus P, Garbe C. Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany.. The Journal of investigative dermatology 2017;137(9):1860-1867. doi:10.1016/j.jid.2017.04.020
  3. Hübner J, Waldmann A, Geller AC, Weinstock MA, Eisemann N, Noftz M, Bertram S, Nolte S, Volkmer B, Greinert R, Breitbart E, Katalinic A. Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma.. British journal of cancer 2017;116(2):253-259. doi:10.1038/bjc.2016.390
  4. Pritzkuleit R, Eisemann N, Katalinic A. [The cartographic depiction of regional variation in morbidity : Data analysis options using the example of the small-scale cancer atlas for Schleswig-Holstein].. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2017;60(12):1319-1327. doi:10.1007/s00103-017-2651-5
  5. Holleczek B, Katalinic A. Toward a comprehensive cancer registration in Germany.. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2017;26 Joining forces for better cancer registration in Europe:S132-S138. doi:10.1097/CEJ.0000000000000388
  6. Hammersen F, Lewin P, Gebauer J, Kreitschmann-Andermahr I, Brabant G, Katalinic A, Waldmann A. Sleep quality and health-related quality of life among long-term survivors of (non-) Hodgkin lymphoma in Germany.. PloS one 2017;12(11):e0187673. doi:10.1371/journal.pone.0187673
  7. Brunssen A, Waldmann A, Eisemann N, Katalinic A. Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review.. Journal of the American Academy of Dermatology 2017;76(1):129-139.e10. doi:10.1016/j.jaad.2016.07.045
  8. Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Scheufele R, Wirth MP, Huber J. Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study.. Prostate cancer and prostatic diseases 2017;20(1):61-66. doi:10.1038/pcan.2016.43
  9. Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, Holleczek B, Katalinic A, Luttmann S, Sundquist K, Ressing M, Xu L, Hemminki K. Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries.. International journal of cancer 2017;141(11):2270-2280. doi:10.1002/ijc.30930

2016

  1. Peller M, Katalinic A, Wollenberg B, Teudt IU, Meyer JE. Epidemiology of laryngeal carcinoma in Germany, 1998-2011.. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2016;273(6):1481-1487. doi:10.1007/s00405-016-3922-8
  2. Sirri E, Castro FA, Kieschke J, Jansen L, Emrich K, Gondos A, Holleczek B, Katalinic A, Urbschat I, Vohmann C, Brenner H. Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States.. Pancreas 2016;45(6):908-914. doi:10.1097/MPA.0000000000000588
  3. Pulte D, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Barnes B, Ressing M, Holleczek B, Luttmann S, Brenner H. Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults.. International journal of cancer 2016;139(6):1289-1296. doi:10.1002/ijc.30186
  4. Pulte D, Castro FA, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H. Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century.. Journal of hematology & oncology 2016;9:28. doi:10.1186/s13045-016-0257-2
  5. Merz M, Jansen L, Castro FA, Hillengass J, Salwender H, Weisel K, Scheid C, Luttmann S, Emrich K, Holleczek B, Katalinic A, Nennecke A, Straka C, Langer C, Engelhardt M, Einsele H, Kröger N, Beelen D, Dreger P, Brenner H, Goldschmidt H. Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantation.. European journal of cancer (Oxford, England : 1990) 2016;62:1-8. doi:10.1016/j.ejca.2016.04.004
  6. Katalinic A. [Improved prognosis for symptom-free older women with mammography-detected breast cancer?].. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 2016;192(2):130-132. doi:10.1007/s00066-015-0930-3
  7. Heywang-Köbrunner SH, Schreer I, Hacker A, Noftz MR, Katalinic A. Conclusions for mammography screening after 25-year follow-up of the Canadian National Breast Cancer Screening Study (CNBSS).. European radiology 2016;26(2):342-350. doi:10.1007/s00330-015-3849-2
  8. Eisemann N, Schnoor M, Katalinic A. Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapy.. Hematological oncology 2016;34(2):93-101. doi:10.1002/hon.2198
  9. Eisemann N, Jansen L, Castro FA, Chen T, Eberle A, Nennecke A, Zeissig SR, Brenner H, Katalinic A. Survival with nonmelanoma skin cancer in Germany.. The British journal of dermatology 2016;174(4):778-785. doi:10.1111/bjd.14352
  10. Brenner H, Castro FA, Eberle A, Emrich K, Holleczek B, Katalinic A, Jansen L. Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time.. European journal of cancer (Oxford, England : 1990) 2016;52:102-108. doi:10.1016/j.ejca.2015.10.059
  11. Liu L, O'Donnell P, Sullivan R, Katalinic A, Moser L, de Boer A, Meunier F. Cancer in Europe: Death sentence or life sentence?. European journal of cancer (Oxford, England : 1990) 2016;65:150-155. doi:10.1016/j.ejca.2016.07.007
  12. Chen T, Fallah M, Brenner H, Jansen L, Mai EK, Castro FA, Katalinic A, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist K, Hemminki K. Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries.. Scientific reports 2016;6:22084. doi:10.1038/srep22084
  13. Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M. Declining Bowel Cancer Incidence and Mortality in Germany.. Deutsches Arzteblatt international 2016;113(7):101-106. doi:10.3238/arztebl.2016.0101

2015

  1. Storm HH, Engholm G, Pritzkuleit R, Kejs AMT, Katalinic A, Dunst J, Holländer NH. Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project.. European journal of cancer (Oxford, England : 1990) 2015;51(9):1188-1198. doi:10.1016/j.ejca.2014.11.006
  2. Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M, Dimitrova N, Innos K, Katalinic A, Langseth H, Larrañaga N, Rossi S, Siesling S, Minicozzi P. Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study.. European journal of cancer (Oxford, England : 1990) 2015;51(15):2191-2205. doi:10.1016/j.ejca.2015.07.022
  3. Pulte D, Jansen L, Castro FA, Emrich K, Katalinic A, Holleczek B, Brenner H. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century.. British journal of haematology 2015;171(2):189-196. doi:10.1111/bjh.13537
  4. Katalinic A. [Commentary on the article "Skin cancer screening in Germany" by Blum et al].. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2015;66(7):540-541. doi:10.1007/s00105-015-3642-9
  5. Hübner J, Noftz MR, Schnoor M, Katalinic A. [Erratum to: Screening for colorectal, skin, breast and prostate cancer. Essential knowledge for counseling].. Der Internist 2015;56(6):716. doi:10.1007/s00108-014-3642-3
  6. Haug U, Rösch T, Hoffmeister M, Katalinic A, Brenner H, Becker N. [Implementing an Organised Colorectal Cancer Screening Programme in Germany: Opportunities and Challenges].. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2015;77(11):869-874. doi:10.1055/s-0034-1377027
  7. Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Stabenow R, Froehner M, Huber J. Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2015;115(1):90-95. doi:10.1016/j.radonc.2015.02.024
  8. Rudolph C, Schnoor M, Eisemann N, Katalinic A. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010.. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2015;13(8):788-797. doi:10.1111/ddg.12690
  9. Peters E, Anzeneder T, Jackisch C, Dimpfl T, Kunz G, Katalinic A, Waldmann A. The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-up.. Deutsches Arzteblatt international 2015;112(35-36):577-584. doi:10.3238/arztebl.2015.0577
  10. Katalinic A, Eisemann N, Waldmann A. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.. Deutsches Arzteblatt international 2015;112(38):629-634. doi:10.3238/arztebl.2015.0629
  11. Katalinic A. [Cancer screening-- sense or nonsense?].. Oncology research and treatment 2015;38 Suppl 3:12. doi:10.1159/000381374
  12. Jansen L, Castro FA, Gondos A, Krilaviciute A, Barnes B, Eberle A, Emrich K, Hentschel S, Holleczek B, Katalinic A, Brenner H. Recent cancer survival in Germany: an analysis of common and less common cancers.. International journal of cancer 2015;136(11):2649-2658. doi:10.1002/ijc.29316
  13. Gebauer J, Fick EM, Waldmann A, Langer T, Kreitschmann-Andermahr I, Lehnert H, Katalinic A, Brabant G. Self-reported endocrine late effects in adults treated for brain tumours, Hodgkin and non-Hodgkin lymphoma: a registry based study in Northern Germany.. European journal of endocrinology 2015;173(2):139-148. doi:10.1530/EJE-15-0174
  14. Eisemann N, Waldmann A, Garbe C, Katalinic A. Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening.. Medical decision making : an international journal of the Society for Medical Decision Making 2015;35(2):243-254. doi:10.1177/0272989X14543106
  15. Fick EM, Katalinic A, Waldmann A. The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany.. Cancer research and treatment 2015;47(4):747-756. doi:10.4143/crt.2014.099
  16. Eisemann N, Nolte S, Schnoor M, Katalinic A, Rohde V, Waldmann A. The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study.. BMC urology 2015;15:28. doi:10.1186/s12894-015-0025-6
  17. Eberle A, Jansen L, Castro F, Krilaviciute A, Luttmann S, Emrich K, Holleczek B, Nennecke A, Katalinic A, Brenner H. Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients.. Lung cancer (Amsterdam, Netherlands) 2015;90(3):528-533. doi:10.1016/j.lungcan.2015.10.007
  18. Chen T, Fallah M, Jansen L, Castro FA, Krilavicuite A, Katalinic A, Eisemann N, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist J, Brenner H, Hemminki K. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries.. Cancer letters 2015;369(1):152-166. doi:10.1016/j.canlet.2015.08.014
  19. Castro FA, Jansen L, Krilaviciute A, Katalinic A, Pulte D, Sirri E, Ressing M, Holleczek B, Luttmann S, Brenner H. Survival of patients with gastric lymphoma in Germany and in the United States.. Journal of gastroenterology and hepatology 2015;30(10):1485-1491. doi:10.1111/jgh.12989

2014

  1. Zanetti R, Sacchetto L, Calvia M, Bordoni A, Hakulinen T, Znaor A, Møller H, Siesling S, Comber H, Katalinic A, Rosso S. Economic evaluation of cancer registration in Europe.. Journal of registry management 2014;41(1):31-37.
  2. Pulte D, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, Holleczek B, Eberle A, Brenner H. Survival of adults with acute lymphoblastic leukemia in Germany and the United States.. PloS one 2014;9(1):e85554. doi:10.1371/journal.pone.0085554
  3. Waldmann A, Anzeneder T, Katalinic A. Patients and Methods of the PATH Biobank - A Resource for Breast Cancer Research.. Geburtshilfe und Frauenheilkunde 2014;74(4):361-369. doi:10.1055/s-0033-1360263
  4. Eisemann N, Waldmann A, Rohde V, Katalinic A. Quality of life in partners of patients with localised prostate cancer.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2014;23(5):1557-1568. doi:10.1007/s11136-013-0588-1
  5. Eisemann N, Waldmann A, Katalinic A. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2014;57(1):77-83. doi:10.1007/s00103-013-1876-1
  6. Breitbart EW, Choudhury K, Anders MP, Volkmer B, Greinert R, Katalinic A, Tacke J, Keilholz U. Benefits and risks of skin cancer screening.. Oncology research and treatment 2014;37 Suppl 3:38-47. doi:10.1159/000364887
  7. Kapsimalakou S, Waldmann A, Katalinic A, Grande-Nagel I, Fischer D, Barkhausen J, Vogt FM. Follow-up of probably benign lesions in non-screening breast diagnostics.. Archives of gynecology and obstetrics 2014;290(3):543-551. doi:10.1007/s00404-014-3233-5
  8. Hübner J, Noftz MR, Schnoor M, Katalinic A. [Screening for colorectal, skin, breast and prostate cancer. Essential knowledge for counseling].. Der Internist 2014;55(10):1171-1181. doi:10.1007/s00108-014-3601-z
  9. Eisemann N, Waldmann A, Geller AC, Weinstock MA, Volkmer B, Greinert R, Breitbart EW, Katalinic A. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence.. The Journal of investigative dermatology 2014;134(1):43-50. doi:10.1038/jid.2013.304

2013

  1. Waldmann A, Schubert D, Katalinic A. Normative data of the EORTC QLQ-C30 for the German population: a population-based survey.. PloS one 2013;8(9):e74149. doi:10.1371/journal.pone.0074149
  2. Waldmann A, Eisemann N, Katalinic A. Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends.. Geburtshilfe und Frauenheilkunde 2013;73(2):123-129. doi:10.1055/s-0032-1328266
  3. Stang A, Jansen L, Trabert B, Rusner C, Eberle A, Katalinic A, Emrich K, Holleczek B, Brenner H. Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age.. Cancer epidemiology 2013;37(4):492-497. doi:10.1016/j.canep.2013.03.017
  4. Schnoor M, Hallof A, Hergert-Lüder D, Katalinic A, Waldmann A. [Reasons for non-participation in mammography screening--a survey in Schleswig-Holstein, Germany].. Deutsche medizinische Wochenschrift (1946) 2013;138(45):2289-2294. doi:10.1055/s-0033-1349585
  5. Rusner C, Trabert B, Katalinic A, Kieschke J, Emrich K, Stang A. Incidence patterns and trends of malignant gonadal and extragonadal germ cell tumors in Germany, 1998-2008.. Cancer epidemiology 2013;37(4):370-373. doi:10.1016/j.canep.2013.04.003
  6. Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Brenner H. Survival of patients with non-Hodgkin lymphoma in Germany in the early 21st century.. Leukemia & lymphoma 2013;54(5):979-985. doi:10.3109/10428194.2012.734616
  7. Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H. Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany.. PloS one 2013;8(7):e68077. doi:10.1371/journal.pone.0068077
  8. Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Brenner H. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up.. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2013;22(3):210-214. doi:10.1097/CEJ.0b013e3283592c62
  9. Listl S, Jansen L, Stenzinger A, Freier K, Emrich K, Holleczek B, Katalinic A, Gondos A, Brenner H. Survival of patients with oral cavity cancer in Germany.. PloS one 2013;8(1):e53415. doi:10.1371/journal.pone.0053415
  10. Greiner F, Nolte S, Waldmann A, Katalinic A, Breitbart EW. [Collection and processing of personal data to evaluate cancer screening programmes - results of a survey of the German population in light of the bill 'early detection of cancer and cancer registries'].. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2013;75(11):751-753. doi:10.1055/s-0033-1355420
  11. Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Meyer M, Brenner H. Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stage.. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2013;22(1):59-67. doi:10.1097/CEJ.0b013e3283552e28
  12. Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Jansen L, Brenner H. A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects.. Cancer medicine 2013;2(5):718-724. doi:10.1002/cam4.116
  13. Fick EM, Anzeneder T, Katalinic A, Waldmann A. Bisphosphonates and their Role in Therapy for Breast Cancer - Results from the PATH Biobank.. Geburtshilfe und Frauenheilkunde 2013;73(5):412-421. doi:10.1055/s-0032-1328502
  14. Eisemann N, Waldmann A, Katalinic A. Epidemiology of Breast Cancer - Current Figures and Trends.. Geburtshilfe und Frauenheilkunde 2013;73(2):130-135. doi:10.1055/s-0032-1328075

2012

  1. Waldmann A, Kapsimalakou S, Katalinic A, Grande-Nagel I, Stoeckelhuber BM, Fischer D, Barkhausen J, Vogt FM. Benefits of the quality assured double and arbitration reading of mammograms in the early diagnosis of breast cancer in symptomatic women.. European radiology 2012;22(5):1014-1022. doi:10.1007/s00330-011-2334-9
  2. Waldmann A, Adrich S, Eisemann N, Fauteck H, Grande-Nagel I, Schaefer FKW, Vorkefeld M, Warnecke C, Weidner K, Wilke C, Katalinic A. [Structure and process quality of quality-assured mamma diagnostics in Schleswig-Holstein].. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2012;184(2):113-121. doi:10.1055/s-0031-1281983
  3. Schnoor M, Waldmann A, Eberle A, Holleczek B, Katalinic A. Colorectal cancer incidence in Germany: stage-shift 6 years after implementation of a colonoscopy screening program.. Cancer epidemiology 2012;36(5):417-420. doi:10.1016/j.canep.2012.04.008
  4. Rusner C, Bandemer-Greulich U, Engel J, Stegmaier C, Zawinell A, Holleczek B, Katalinic A, Kuss O, Schmidt-Pokrzywniak A, Schubert-Fritschle G, Tillack A, Stang A. Population-based hormone receptor-specific incidence trends of breast cancer in Germany.. Maturitas 2012;73(2):152-157. doi:10.1016/j.maturitas.2012.06.008
  5. Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H. Survival from colorectal cancer in Germany in the early 21st century.. British journal of cancer 2012;106(11):1875-1880. doi:10.1038/bjc.2012.189
  6. Waldmann A, Nolte S, Geller AC, Katalinic A, Weinstock MA, Volkmer B, Greinert R, Breitbart EW. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations.. Archives of dermatology 2012;148(8):903-910. doi:10.1001/archdermatol.2012.893
  7. Waldmann A, Nolte S, Weinstock MA, Breitbart EW, Eisemann N, Geller AC, Greinert R, Volkmer B, Katalinic A. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.. British journal of cancer 2012;106(5):970-974. doi:10.1038/bjc.2012.22
  8. Perl M, Waldmann A, Pritzkuleit R, Katalinic A. [Temporal changes in quality of life after prostate carcinoma].. Der Urologe. Ausg. A 2012;51(5):706-712. doi:10.1007/s00120-011-2788-z
  9. Katalinic A, Waldmann A, Weinstock MA, Geller AC, Eisemann N, Greinert R, Volkmer B, Breitbart E. Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening.. Cancer 2012;118(21):5395-5402. doi:10.1002/cncr.27566
  10. Jansen L, Gondos A, Eberle A, Emrich K, Holleczek B, Katalinic A, Brenner H. Cancer survival in Eastern and Western Germany after the fall of the iron curtain.. European journal of epidemiology 2012;27(9):689-693. doi:10.1007/s10654-012-9723-5
  11. Hiripi E, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Nennecke A, Brenner H. Survival of stomach and esophagus cancer patients in Germany in the early 21st century.. Acta oncologica (Stockholm, Sweden) 2012;51(7):906-914. doi:10.3109/0284186X.2012.673732
  12. Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ. Recent trends in incidence and mortality of oral and pharyngeal cancer in Schleswig-Holstein in Northern Germany.. Community dental health 2012;29(4):268-273.
  13. Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, Katalinic A. Systematic skin cancer screening in Northern Germany.. Journal of the American Academy of Dermatology 2012;66(2):201-211. doi:10.1016/j.jaad.2010.11.016
  14. Hiripi E, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Brenner H. Survival from common and rare cancers in Germany in the early 21st century.. Annals of oncology : official journal of the European Society for Medical Oncology 2012;23(2):472-479. doi:10.1093/annonc/mdr131
  15. Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ. Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany.. Journal of cancer research and clinical oncology 2012;138(3):431-437. doi:10.1007/s00432-011-1118-6
  16. Eisemann N, Jansen L, Holleczek B, Waldmann A, Luttmann S, Emrich K, Hauschild A, Brenner H, Katalinic A. Up-to-date results on survival of patients with melanoma in Germany.. The British journal of dermatology 2012;167(3):606-612. doi:10.1111/j.1365-2133.2012.11039.x
  17. Chen T, Jansen L, Gondos A, Ressing M, Holleczek B, Katalinic A, Brenner H. Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage.. BMC cancer 2012;12:128. doi:10.1186/1471-2407-12-128

2011

  1. Obi N, Waldmann A, Schäfer F, Schreer I, Katalinic A. Impact of the Quality assured Mamma Diagnostic (QuaMaDi) programme on survival of breast cancer patients.. Cancer epidemiology 2011;35(3):286-292. doi:10.1016/j.canep.2010.09.001
  2. Obi N, Waldmann A, Babaev V, Katalinic A. [Record linkage of a large clinical practice patient cohort with the Cancer Registry Schleswig-Holstein].. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2011;73(7):452-458. doi:10.1055/s-0030-1252037
  3. Waldmann A, Nolte S, Pritzkuleit R, Breitbart EW, Katalinic A. Different aspects of self-reported quality of life in 450 german melanoma survivors.. Cancers 2011;3(2):2316-2332. doi:10.3390/cancers3022316
  4. Eisemann N, Waldmann A, Katalinic A. Imputation of missing values of tumour stage in population-based cancer registration.. BMC medical research methodology 2011;11:129. doi:10.1186/1471-2288-11-129
  5. Dittmer C, Katalinic A, Mundhenke C, Thill M, Fischer D. Epidemiology of vulvar and vaginal cancer in Germany.. Archives of gynecology and obstetrics 2011;284(1):169-174. doi:10.1007/s00404-011-1850-9
  6. Brenner H, Altenhofen L, Katalinic A, Lansdorp-Vogelaar I, Hoffmeister M. Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database.. American journal of epidemiology 2011;174(10):1140-1146. doi:10.1093/aje/kwr188

2010

  1. Waldmann A, Eberle A, Hentschel S, Holleczek B, Katalinic A. [Population-based incidence rates of colorectal neoplasms (2000 - 2006) - has systematic colonoscopy screening an impact on incidence? A combined analysis of cancer registry data of the Federal States of Bremen, Hamburg, Saarland and Schleswig-Holstein].. Zeitschrift fur Gastroenterologie 2010;48(12):1358-1366. doi:10.1055/s-0029-1245602
  2. Pritzkuleit R, Beske F, Katalinic A. [Demographic change and cancer].. Onkologie 2010;33 Suppl 7:19-24. doi:10.1159/000319738
  3. Pritzkuleit R, Beske F, Katalinic A. [Disease numbers in pneumology - a projection to 2060].. Pneumologie (Stuttgart, Germany) 2010;64(9):535-540. doi:10.1055/s-0030-1255637
  4. Waldmann A, Dreckschmidt J, Pritzkuleit R, Katalinic A. [Test-retest reliability of the OVIS Questionnaire--an instrument to evaluate oncological care from a patient's point of view].. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2010;72(10):707-713. doi:10.1055/s-0029-1242787
  5. Stang A, Katalinic A, Dieckmann KP, Pritzkuleit R, Stabenow R. A novel approach to estimate the German-wide incidence of testicular cancer.. Cancer epidemiology 2010;34(1):13-19. doi:10.1016/j.canep.2009.11.007
  6. Schaefer FKW, Waldmann A, Katalinic A, Wefelnberg C, Heller M, Jonat W, Schreer I. Influence of additional breast ultrasound on cancer detection in a cohort study for quality assurance in breast diagnosis--analysis of 102,577 diagnostic procedures.. European radiology 2010;20(5):1085-1092. doi:10.1007/s00330-009-1641-x
  7. Katalinic A, Peters E, Beske F, Pritzkuleit R. Projection of Morbidity 2030 and 2050: Impact for the National Health System and Blood Supply.. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2010;37(3):155-159. doi:10.1159/000313993
  8. Geller AC, Greinert R, Sinclair C, Weinstock MA, Aitken J, Boniol M, Capellaro M, Doré JF, Elwood M, Fletcher SW, Gallagher R, Gandini S, Halpern AC, Katalinic A, Lucas R, Marghoob AA, Nolte S, Schüz J, Tucker MA, Volkmer B, Breitbart E. A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009).. Cancer epidemiology 2010;34(3):355-358. doi:10.1016/j.canep.2010.03.006

2009

  1. Schafmayer C, Buch S, Völzke H, von Schönfels W, Egberts JH, Schniewind B, Brosch M, Ruether A, Franke A, Mathiak M, Sipos B, Henopp T, Catalcali J, Hellmig S, ElSharawy A, Katalinic A, Lerch MM, John U, Fölsch UR, Fändrich F, Kalthoff H, Schreiber S, Krawczak M, Tepel J, Hampe J. Investigation of the colorectal cancer susceptibility region on chromosome 8q24.21 in a large German case-control sample.. International journal of cancer 2009;124(1):75-80. doi:10.1002/ijc.23872
  2. Rohde V, Weidner W, Katalinic A. Decrease in prostate cancer incidence and mortality in Germany - effects of opportunistic PSA screening or more?. Urologia internationalis 2009;83(2):134-140. doi:10.1159/000230012
  3. Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldmann A. Trends in hormone therapy and breast cancer incidence - results from the German Network of Cancer Registries.. Pathobiology : journal of immunopathology, molecular and cellular biology 2009;76(2):90-97. doi:10.1159/000201677
  4. Waldmann A, Rohde V, Bremner K, Krahn M, Kuechler T, Katalinic A. Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P).. BMC cancer 2009;9:295. doi:10.1186/1471-2407-9-295
  5. Waldmann A, Raspe H, Katalinic A. [Colon cancer risk in persons at familial or hereditary risk aged < 55 years].. Zeitschrift fur Gastroenterologie 2009;47(10):1052-1058. doi:10.1055/s-0028-1109515
  6. Katalinic A, Pritzkuleit R, Waldmann A. Recent Trends in Breast Cancer Incidence and Mortality in Germany.. Breast care (Basel, Switzerland) 2009;4(2):75-80. doi:10.1159/000211526
  7. Katalinic A, Raspe H, Waldmann A. [Positive family history of colorectal cancer--use of a questionnaire].. Zeitschrift fur Gastroenterologie 2009;47(11):1125-1131. doi:10.1055/s-0028-1109469

2008

  1. Waldmann A, Pritzkuleit R, Raspe H, Katalinic A. Guideline-compatible treatment of breast cancer patients: the status quo in schleswig-holstein.. Deutsches Arzteblatt international 2008;105(18):337-343. doi:10.3238/arztebl.2008.0337
  2. Pritzkuleit R, Waldmann A, Raspe H, Katalinic A. The population-based oncological health care study OVIS - recruitment of the patients and analysis of the non-participants.. BMC cancer 2008;8:311. doi:10.1186/1471-2407-8-311
  3. Hüppe D, Hartmann H, Felten G, Kemen M, Tannapfel A, Gillessen A, Katalinic A. [Effectiveness of screening colonoscopy in a community-based study].. Zeitschrift fur Gastroenterologie 2008;46(2):193-200. doi:10.1055/s-2007-963539
  4. Heywang-Köbrunner SH, Schreer I, Heindel W, Katalinic A. Imaging studies for the early detection of breast cancer.. Deutsches Arzteblatt international 2008;105(31-32):541-547. doi:10.3238/arztebl.2008.0541
  5. Beelte AK, Pritzkuleit R, Katalinic A. [Lung cancer incidence and mortality: current trends and projections based on data from Schleswig-Holstein].. Deutsche medizinische Wochenschrift (1946) 2008;133(28-29):1487-1492. doi:10.1055/s-2008-1081095
  6. Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy.. Breast cancer research and treatment 2008;107(3):427-430. doi:10.1007/s10549-007-9566-z

2007

  1. Schafmayer C, Buch S, Egberts JH, Franke A, Brosch M, El Sharawy A, Conring M, Koschnick M, Schwiedernoch S, Katalinic A, Kremer B, Fölsch UR, Krawczak M, Fändrich F, Schreiber S, Tepel J, Hampe J. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.. International journal of cancer 2007;121(3):555-558. doi:10.1002/ijc.22735
  2. Katalinic A, Bartel C, Raspe H, Schreer I. Beyond mammography screening: quality assurance in breast cancer diagnosis (The QuaMaDi Project).. British journal of cancer 2007;96(1):157-161. doi:10.1038/sj.bjc.6603506
  3. Waldmann A, Pritzkuleit R, Raspe H, Katalinic A. The OVIS study: health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(5):767-776. doi:10.1007/s11136-006-9161-5
  4. Waldmann A, Lautz E, Hampe J, Schreiber S, Schafmayer C, Katalinic A. [Utilization of inpatient rehabilitation of younger patients with colorectal neoplasms--results of the project "Popgen-colorectal cancer"].. Die Rehabilitation 2007;46(6):349-355. doi:10.1055/s-2007-973828
  5. Waldmann A, Lautz E, Hampe J, Schreiber S, Schafmayer C, Raspe H, Katalinic A. [Description of the medical care of younger patients (<65 years) with colorectal cancer in Schleswig-Holstein--are diagnostics and therapy compliant with the actual S3-guidelines?].. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2007;69(4):216-223. doi:10.1055/s-2007-973840

2006

  1. Stang A, Streller B, Katalinic A, Lehnert M, Eisinger B, Kaatsch P, Jöckel KH. Incidence of skin lymphoma in Germany.. Annals of epidemiology 2006;16(3):214-222. doi:10.1016/j.annepidem.2005.04.002
  2. Rohde V, Diemer T, Hauck E, Bestmann B, Miller J, Schröder H, Weidner W, Katalinic A. Prescription practice for LH-RH analogs and androgen receptor antagonists in the treatment of advanced prostate cancer in Germany (1993-2003).. Urologia internationalis 2006;77(4):311-316. doi:10.1159/000096334

2005

  1. Lehnert M, Eberle A, Hentschel S, Katalinic A, Kieschke J, Schmidtmann I, Schubert-Fritschle G, Stegmaier C, Hense HW. [Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany -- incidence, clinical parameters, variations in recording].. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2005;67(10):729-735. doi:10.1055/s-2005-858696

2004

  1. Katalinic A. [Population-based cancer registration in Germany. Essentials and perspectives].. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2004;47(5):422-428. doi:10.1007/s00103-004-0827-2

2003

  1. Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).. The British journal of dermatology 2003;149(6):1200-1206. doi:10.1111/j.1365-2133.2003.05554.x
  2. Katalinic A, Holzmann M, Kunze U. [Relation of breast cancer tumour stage and the degree of registration in a population-based cancer registry].. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2003;65(8-9):509-515. doi:10.1055/s-2003-42388
Direktzugriff
zum Melderportallink icon